For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...

A recent review revisited the question of whether inhalers and nebulizers have similar effectiveness to manage stable chronic obstructive pulmonary disease (COPD). A recent review revisited the ...

Breathing devices, including inhalers, nebulizers, and larger devices, can help improve your breathing with COPD. Which device a doctor recommends can depend on your symptoms. If you’re living with ...

The usual Perforomist dosage for COPD is one treatment with a nebulizer twice per day. Specific dosages may vary depending on factors such as other medications you may be taking. It’s important to use ...

Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system. The SUN-101/eFlow system, described as a ...

The first DTC ad campaign for Viatris and Theravance’s COPD nebulizer therapy Yupelri aims to show the freedom of the once-daily treatment. In a newly debuted TV ad, an older woman celebrates her ...

Medicare classifies nebulizers as durable medical equipment (DME), which is covered under Part B. Part A may cover costs if needed during inpatient care in a clinic, hospital, or nursing facility.

For individuals living with COPD, small changes may make a difference. Byline: Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of ...